Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation

[1] Beitz JM(2014)Parkinson's disease: a review Front Biosci (Schol Ed) 6 65-74

[2] Obeso JA(2000)Pathophysiology of the basal ganglia in Parkinson’s disease Trends Neurosci 23 S8-19

[3] Rodriguez-Oroz MC(2016)Neuroprotective and therapeutic strategies against Parkinson’s disease: recent perspectives Int J Mol Sci 17 6-58

[4] Rodriguez M(2011)Epidemiology and etiology of Parkinson’s disease: a review of the evidence Eur J Epidemiol 26 S1-1391

[5] Lanciego JL(2011)Animal models of Parkinson’s disease: a source of novel treatments and clues to the cause of the disease Br J Pharmacol 164 1357-120

[6] Artieda J(2013)Oxidative damage to macromolecules in human Parkinson disease and the rotenone model Free Radic Biol Med 62 111-407

[7] Gonzalo N(2017)Metformin lowers alpha-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson’s disease Neuropharmacology 125 396-11

[8] Sarkar S(2016)Metformin prevents dopaminergic neuron death in MPTP/P-induced mouse model of Parkinson’s disease via autophagy and mitochondrial ROS clearance Int J Neuropsychopharmacol 19 9-754

[9] Raymick J(2016)Metformin prevents nigrostriatal dopamine degeneration independent of ampk activation in dopamine neurons PLoS One 11 e0159381-109

[10] Imam S(2014)The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro Neurobiol Dis 63 1-2459

[1] Beitz JM(2014)Parkinson's disease: a review Front Biosci (Schol Ed) 6 65-74

[2] Obeso JA(2000)Pathophysiology of the basal ganglia in Parkinson’s disease Trends Neurosci 23 S8-19

[3] Rodriguez-Oroz MC(2016)Neuroprotective and therapeutic strategies against Parkinson’s disease: recent perspectives Int J Mol Sci 17 6-58

[4] Rodriguez M(2011)Epidemiology and etiology of Parkinson’s disease: a review of the evidence Eur J Epidemiol 26 S1-1391

[5] Lanciego JL(2011)Animal models of Parkinson’s disease: a source of novel treatments and clues to the cause of the disease Br J Pharmacol 164 1357-120

[6] Artieda J(2013)Oxidative damage to macromolecules in human Parkinson disease and the rotenone model Free Radic Biol Med 62 111-407

[7] Gonzalo N(2017)Metformin lowers alpha-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson’s disease Neuropharmacology 125 396-11

[8] Sarkar S(2016)Metformin prevents dopaminergic neuron death in MPTP/P-induced mouse model of Parkinson’s disease via autophagy and mitochondrial ROS clearance Int J Neuropsychopharmacol 19 9-754

[9] Raymick J(2016)Metformin prevents nigrostriatal dopamine degeneration independent of ampk activation in dopamine neurons PLoS One 11 e0159381-109

[10] Imam S(2014)The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro Neurobiol Dis 63 1-2459